{
    "Trade/Device Name(s)": [
        "Synthgene Home Test HCG Test Strip",
        "Synthgene Home Test HCG Test Cassette",
        "Synthgene Home Test HCG Test Midstream"
    ],
    "Submitter Information": "Nanjing Synthgene Medical Technology Co., Ltd.",
    "510(k) Number": "K242135",
    "Predicate Device Reference 510(k) Number(s)": [
        "K192123"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCX"
    ],
    "Summary Letter Date": "December 20, 2024",
    "Summary Letter Received Date": "December 20, 2024",
    "Submission Date": "January 24, 2025",
    "Regulation Number(s)": [
        "21 CFR 862.1155"
    ],
    "Regulation Name(s)": [
        "Human Chorionic Gonadotropin (HCG) Test System"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Human Chorionic Gonadotropin (HCG)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Urine cup"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Double antibody sandwich"
    ],
    "Methodologies": [
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Strip",
        "Cassette",
        "Midstream"
    ],
    "Document Summary": "FDA 510(k) summary for Synthgene Home Test HCG pregnancy test strip, cassette, and midstream formats for qualitative detection of HCG in urine",
    "Indications for Use Summary": "Qualitative detection of human chorionic gonadotropin in urine to aid in the early detection of pregnancy",
    "fda_folder": "Clinical Chemistry"
}